127 results on '"Lenhard, James M"'
Search Results
2. Fatty Acids and Eicosanoids Regulate Gene Expression through Direct Interactions with Peroxisome Proliferator-Activated Receptors α and γ
3. Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain
4. Identification of Proteins Involved in Endosome Fusion: Implications for Toxin Activity
5. Developing Dictyostelium Cells Contain the Lysosomal Enzyme α-Mannosidase in a Secretory Granule
6. Screening blood donors for diabetes: analysis of use, accuracy, and cost
7. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662
8. Spousal Influence on Diabetes Self-care: Moderating Effects of Distress and Relationship Quality on Glycemic Control
9. Diabetogenic Effect of a Series of Tricyclic Delta Opioid Agonists Structurally Related to Cyproheptadine
10. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation
11. Development of Infrared Imaging to Measure Thermogenesis in Cell Culture: Thermogenic Effects of Uncoupling Protein-2, Troglitazone, and β-Adrenoceptor Agonists
12. Thiazolidinediones inhibit alkaline phosphatase activity while increasing expression of uncoupling protein, deiodinase, and increasing mitochondrial mass in C3H10T1/2 cells
13. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
14. Chapter 13. In vitro and in vivo approaches to studying antiretroviral therapy (ART)-induced metabolic complications
15. Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments
16. A prostaglandin J(sub 2) metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation
17. Abacavir and Diabetes
18. Bone mineral loss in HIV-positive patients receiving antiretroviral therapy
19. A Novel N-Aryl Tyrosine Activator of Peroxisome Proliferator-Activated Receptor-gamma Reverses the Diabetic Phenotype of the Zucker Diabetic Fatty Rat
20. Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice
21. [16]In vitro studies of endocytic vesicle fusion
22. [5] Reconstitution of endosome fusion: Identification of factors necessary for fusion competency
23. Select HIV Protease Inhibitors Alter Bone and Fat Metabolism ex Vivo
24. Preclinical developments in type 2 diabetes
25. Muscle Rad Expression and Human Metabolism: Potential Role of the Novel Ras-Related GTPase in Energy Expenditure and Body Composition
26. Abacavir and diabetes
27. Metabolic complications associated with antiretroviral therapy
28. Dietary Fat Alters HIV Protease Inhibitor–Induced Metabolic Changes in Mice
29. HIV protease inhibitors block adipogenesis and increase lipolysis in vitro
30. Stimulation of vitamin A 1 acid signaling by the HIV protease inhibitor indinavir
31. Spousal Influence on Diabetes Self-care: Moderating Effects of Distress and Relationship Quality on Glycemic Control.
32. 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: Part 2. Pyridazine-based analogs
33. 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: Urea-based analogs
34. A candidate-gene association study of topiramate-induced weight loss in obese patients with and without type 2 diabetes mellitus
35. Identification of Diaryl Ether-Based Ligands for Estrogen-Related Receptor α as Potential Antidiabetic Agents
36. 2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IV
37. Structure-Based Design of Potent Retinoid X Receptor α Agonists
38. β-Adrenoceptor Assays
39. HIV Protease Inhibitors Stimulate Hepatic Triglyceride Synthesis
40. Stimulation of vitamin A1 acid signaling by the HIV protease inhibitor indinavir
41. Cardiovascular Autonomic Neuropathy
42. IBC’s 6th International Symposium on Obesity and 3rd International Symposium on Insulin Resistance: March 22-25, 1999, Washington, DC
43. N-(2-Benzoylphenyl)-l-tyrosine PPARγ Agonists. 1. Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents
44. N-(2-Benzoylphenyl)-l-tyrosine PPARγ Agonists. 3. Structure−Activity Relationship and Optimization of the N-Aryl Substituent
45. N-(2-Benzoylphenyl)-l-tyrosine PPARγ Agonists. 2. Structure−Activity Relationship and Optimization of the Phenyl Alkyl Ether Moiety
46. Effects of troglitazone and metformin on glucose and lipid metabolism
47. Identification of Rad's effector-binding domain, intracellular localization, and analysis of expression in Pima Indians
48. Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs
49. Phosphorylation of a cAMP-specific phosphodiesterase (HSPDE4B2B) by mitogen-activated protein kinase
50. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.